Core Laboratories NV
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.0% | +0.3% | +1.7% | +0.4% | -1.7% | +0.2% | +1.8% | -1.8% | -1.2% | +0.6% | -0.2% | |
| – | -2.4% | +2.6% | +2.0% | +0.7% | -3.7% | +1.0% | +3.9% | -4.5% | -5.4% | -0.1% | 0.0% | |
| – | -9.0% | -1.4% | +18.7% | +21.4% | -10.8% | +15.4% | +41.1% | -17.8% | -11.4% | +0.5% | -0.4% | |
| – | -9.0% | -1.4% | +18.7% | +21.4% | -10.8% | +15.4% | +41.1% | -17.8% | -11.4% | +0.5% | -0.4% | |
| – | +1.3% | +5.3% | +0.9% | +1.3% | -3.8% | +2.9% | -2.3% | -2.3% | -3.3% | -4.6% | +0.8% | |
| – | -4.5% | -1.4% | -1.1% | -6.3% | -9.3% | -0.6% | +1.3% | -2.6% | -6.4% | +6.0% | +0.3% | |
| – | – | – | – | – | -0.5% | +1.2% | -1.5% | -0.7% | +1.2% | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.6% | +0.0% | +5.8% | +0.0% | +0.0% | |
| – | -4.8% | -1.8% | -1.9% | -1.9% | -2.2% | -1.9% | -1.7% | -1.0% | +16.6% | -3.2% | -2.0% | |
| – | -1.8% | -1.7% | +0.4% | -2.3% | -3.3% | -0.2% | +0.8% | -6.2% | -0.7% | +0.3% | -1.5% | |
| – | +4.6% | -3.0% | +14.2% | -2.7% | +2.8% | +6.3% | +1.0% | -8.6% | +10.7% | -1.2% | -3.5% | |
| – | +3.9% | +2.5% | +5.9% | +3.5% | -6.5% | +9.0% | -1.3% | -0.3% | -0.2% | +5.6% | -1.3% | |
| – | -1.7% | -3.0% | +13.5% | -8.8% | +2.7% | +11.4% | +8.3% | -11.4% | +0.9% | +7.3% | +0.5% | |
| – | -8.3% | -1.7% | -7.9% | -5.2% | -9.8% | -1.4% | +0.2% | -8.4% | -3.4% | +3.8% | -0.5% | |
| – | +0.1% | +3.3% | +3.5% | +4.4% | +0.5% | +0.6% | +3.1% | +3.9% | -2.0% | +1.1% | +1.4% | |
| – | +1.5% | +2.3% | +6.9% | +8.5% | +4.8% | -0.4% | +6.8% | +8.6% | -0.5% | -0.7% | +3.2% | |
| – | -0.1% | +0.3% | +0.1% | +0.2% | -0.1% | -2.1% | +1.6% | -0.9% | -1.2% | -0.9% | +1.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.